Keratosis pilaris (KP) is a follicular hyperkeratosis disorder which is frequently detected in the adult population (44%), mostly in female adolescents (80%). It is a genetic autodominant dermatosis with variable penetrance, but no specific gene association has been determined, even though association to the presence of chromosome 18p deletion has been reported in some cases. We report the case of a 51-yearold Caucasian woman affected by keratosis pilaris gradually progressing with age and with a story of multiple abortions. Standard karyotype and CGH array analyses did not reveale any genetic abnormality. Virological analyses detected the presence ofHPV 36 DNA inside the dorsum biopsy, leading to hypothesize its involvement in the evolution of the lesion. Clinical history and patient examination led the diagnosis of an idiopathic case of Ulerythema ophryogenes. The analysis of more cases could be useful to verify the involvement of cutaneous HPV in the progression of the clinical manifestation of the KP variants.
Keratosis pilaris (KP) is a common inherited disorder, affecting nearly 50-80% of all adolescents and approximately 40% of adults (1) .
It is characterized by follicular hyperkeratosis and the presence of small, folliculocentric keratotic papules, commonly grouped on the extensor area of the upper arms, upper legs and buttocks; other possible locations include the trunk and the face-ulerythema ophryogenes (2) (3) . Keratotic itchy follicular papules are surrounded by erythema. The course of KP is characterized by a progressive inflammation leading to mild atrophy, with permanent follicular disruption which frequently improves with age.
Generally KP appears in childhood and can remain unchanged or reach peak prevalence during adolescence (4) . KP can be associated to genetic disease or to hormonal changes (5) .
No clear aetiology has been defined. KP is often described in association with other dry skin conditions such as Ichthyosis vulgaris, xerosis and, less commonly, with atopic dermatitis, including conditions of asthma and allergies; autosomal dominant inheritance with variable penetrance has been described (4) .
No specific laboratory tests aid the diagnosis ofKP. The diagnosis of keratosis pilaris is mainly clinical and based on a typical skin appearance and lesion localisation in areas such as the upper arms. Variants of keratosis pilaris include: Keratosis pilaris rubra characterised by the presence of reddened lesions, Keratosis pilaris atrophicans faciei, with facial follicular atrophy (small scar-like depressions), Ulerythema ophryogenes with atrophic involvement of the outer eyebrows, Atrophoderma vermiculata with severe worm-eaten appearance of the cheeks, Keratosis follicularis spinulosa decalvans (a rare familial variant which results in bald areas of the scalp and of the eyebrows) and Lichen spinulosus (keratosis spinulosa) with solitary or multiple grouped lesions of follicular papules topped with scaly spines on the entire body surface. Ulerythema ophryogenes (or Keratosis pilaris atrophicans faciei) is described as an uncommon variant of keratosis pilaris characterized by follicular-based, small horny, red papules of the eyebrows and cheeks; this variant may be complicated and followed by a gradual loss of hair in the affected facial areas (2) . The histopathologic picture, characterized by the presence of keratotic plugs at the follicular orifice, permits to formulate the diagnosis. Histologic changes are dynamic and follow the clinical course of the disease. Notably KP is much more common in Noonan syndrome, a genetically heterogeneous condition with autosomal dominant transmission (6) . Noonan syndrome is characterized by short stature, dysmorphic facial appearance, congenital heart disease, webbed neck, pectus excavatum, and developmental delay of variable degrees. KP is also common to other syndromes caused by mutations in genes which also encode components of the Ras/ mitogen-activated protein kinase (MAPK) pathway, such as the cardiofaciocutaneous (CFC) syndrome. In some cases there seems to be an association between KPlUlerythema ophryogenes and partial monosomy of chromosome 18 (7) .
Case report
We report the case of a 51-year-old Caucasian woman with keratosis pilaris localised on the upper and lower limbs, neck, chest, shoulders and eyebrows, with partial eyebrow loss and inflammatory keratotic papules 1-2 mm in diameter concentrated in the central and lateral portion of the eyebrow arch. In these areas we observed a follicular syndrome with inflammation and atrophy of the follicle bulbs.
The patient referred always having had the hyperkeratotic lesions from the early years of life localised only on the lower limbs associated to xerotic skin over the entire surface of the body. The hyperkeratosis had progressed during the previous ten years and gradually affected arms, legs, trunk and face (cheeks and eyebrows) becoming more severe. During the last previous two years the clinical manifestations had become more aggressive and were associated to eyebrow loss.
The patient referred 3 pregnancies resulting in 2 stillbirths, and one miscarriage during the third month. She referred menopause at 39 years of age.
Both her sisters had similar stories, but not cutaneous symptoms: the first had two miscarriage during the third month, and the other had one miscarriage and one pharmaceutically induced pregnancy resulting in twins. The patient's clinical history was unremarkable: no growth or cardiac alterations were present. Blood routine and metabolic exams were normal, only a mild increase of transaminases and a reduction of glomerular filtration rate were observed.
Since skin biopsy with histopathological examination may be useful in atypical cases, bioptic sample was taken from the dorsum (paravertebral area).
Histopathologic examination of keratosis pilaris (KP) lesion showed little chronic perivascular inflammation (superficial perivascular lymphocytic inflammatory infiltrate) and epidermal hyperkeratosis, hypergranulosis and plugging of individual hair follicles (Fig. 1) .
Because of the multiple pregnancy losses, we considered the possibility that the patient was a heterozygous carrier of a chromosomal rearrangement responsible for both the polyabortivity and the dermatologic condition, such as a balanced translocation with gene mutation at the chromosome break-point. First, a standard karyotype test, which showed a normal karyotype, was performed followed by CGH array analysis. Commercially available NucleoSpin Blood kit (Macherey-Nagel GmbH & Co, Duren, Germany) was used to extract genomic DNA from 2 ml of peripheral blood. An array-CGH analysis (44B Chip; Agilent Technlogies, Walldbronn, Germany) was carried out using the manufacturer's protocol (Agilent Technologies; v5.0). Genomic DNA was hybridized against a pool of reference female DNAs (Promega, Madison, WI). The array was imaged with Feature Extraction software (v8.5) and chromosomal profiles, with a resolution of about 250 Kb, were obtained using the ADM-2 algorithm provided by CGH analytics software (v4.0.73) (Agilent Technologies). The technique detects microdeletions or microduplications, but in this case it also resulted negative. Although karyotype and CGH array were normal, genetic causes such as mutations or small deletions cannot yet be ruled out.
Literature reports frequent aSSOCIatIOn of dyskeratosic lesions with Human Papillomavirus (HPV) DNA presence (8) (9) . In view of the fact that KP is an alteration of the epidermal differentiation which leads to dyskeratosis, in some way similar to psoriasis, an involvement of HPV cannot be excluded. Therefore, a small portion of the biopsy taken from the dorsum, after rubbing the skin with alcohol swabs in order to remove the superficial cells and to eliminate all the possible contaminating factors, was used for HPV testing (10) . DNA was extracted from the bioptic sample to search for the presence of HPV; firstly aliquot of the purified DNA was employed in PCR assay to check the suitability of the sample (HLA gene), then it was subjected to different amplifications in order to detect a broad spectrum of HPV types. A method amplifies a portion of L1 gene, while the other amplifies the complete E6/partial E7 genes (11) detecting about 45 genital HPV types. Both techniques gave negative results. Moreover, a nested PCR was performed utilising consensus primers for detecting cutaneous HPVs (12) . Each PCR reaction was electrophoresed on agarose gel in parallel with positive and negative controls and PCR products of the proper length were purified and sequenced by automatic DNA sequencer (Applied Biosystem, mod.370A), according to the manufacturer's specifications (Amplicycle Kit, Applied Biosystem). Sequence homology was determined by BLAST and Clustal W programs.
A fragment of about 350 bp was identified by the nested PCR, showing 97% identity, with coverage of 98%, to cutaneous HPV36 (Fig. 2) . The cutaneous HPV are classified into different genera: HPV 36 belongs to Beta-papillomavirus genus. This genus is divided into 5 distinct species containing related types: beta-l species contains HPV36 and HPV5, 8, 12, 19, 20, 21, 24, 25, 47 , and 93. BetaPapillomavirus species 1 are primarily found in benign lesions (13) , but a recent study demonstrated that HPV36 has a significant in vitro transforming potential (14) .
DISCUSSION
KP cases with no systemic disorders are only clinically diagnosed. A positive family history of KP was demonstrated only in 39% of the patients. In rare cases the syndrome is associated to multiple miscarriages, such as in this report. Clinical anamnesis of the patient induced to suspect the presence of a genetic disorder, but the performed analyses did not reveal short rearrangements or chromosomal unbalance, while histology analysis confirmed the clinical hypothesis of KP.
Clinical history and patient examination lead to formulate the diagnosis of an idiopathic case of Ulerythema ophryogenes.
Since HPV have been frequently associated with epidermal differentiation disorders, a biopsy sample from affected skin of the patients was analysed in order to detect HPV DNA. The hypothesis was to verify whether there was a relation between the clinical evolution of the disease and the presence of HPV as an aggravating factor (9, 15) .
It cannot be excluded that HPV DNA found in the sample might merely be a passenger that has no relevance to disease progress. The analysis of more KP cases is needed to establish a relationship of HPV, or in particular HPV36, with KP.
